Company Filing History:
3 out of 69 
2 out of 12 
2 out of 2 Years Active: 2019-2025
Title: Innovations by Hans Jakob Kristoffer Famm
Introduction
Hans Jakob Kristoffer Famm is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of neuromodulation, particularly in the treatment of metabolic disorders. With a total of 5 patents to his name, Famm's work is paving the way for innovative medical devices that can improve health outcomes.
Latest Patents
Famm's latest patents include groundbreaking inventions such as "Systems and methods for neuromodulation of a carotid sinus nerve." This invention refers to a device designed to inhibit the neural activity of the carotid sinus nerve (CSN) or carotid body of a subject. The device comprises one or more transducers that apply a signal to the CSN or associated carotid body, controlled by a controller. The physiological responses produced by this device include increased insulin sensitivity, improved glucose tolerance, decreased plasma glucose concentration, reduced subcutaneous fat content, and a reduction in obesity.
Another significant patent is the "Neuromodulation device and method for treating metabolic disorders." Similar to the previous invention, this device aims to inhibit the neural activity of the CSN or carotid body, leading to beneficial physiological responses in subjects suffering from metabolic disorders.
Career Highlights
Throughout his career, Famm has worked with prominent companies in the medical technology sector. Notable among these are Galvani Bioelectronics Limited and Presidio Medical, Inc. His work in these organizations has contributed to the advancement of neuromodulation technologies.
Collaborations
Famm has collaborated with talented individuals in his field, including Daniel John Chew and Silvia Margarida Vilares Santos Conde. These collaborations have likely enriched his research and development efforts.
Conclusion
Hans Jakob Kristoffer Famm is a distinguished inventor whose work in neuromodulation is making a significant impact on the treatment of metabolic disorders. His innovative patents and collaborations highlight his commitment to advancing medical technology for better health outcomes.